Merdad Parsey - 10 Mar 2024 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role
Chief Medical Officer
Signature
/s/ Amy Kim by Power of Attorney for Merdad Parsey
Issuer symbol
GILD
Transactions as of
10 Mar 2024
Net transactions value
-$360,801
Form type
4
Filing time
11 Mar 2024, 21:14:09 UTC
Previous filing
29 Feb 2024
Next filing
02 Apr 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GILD Common Stock Options Exercise +3,455 +3.7% 96,161 10 Mar 2024 Direct F1
transaction GILD Common Stock Options Exercise +6,946 +7.2% 103,107 10 Mar 2024 Direct F1
transaction GILD Common Stock Tax liability $360,801 -4,803 -4.7% $75.12 98,304 10 Mar 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Restricted Stock Unit Options Exercise -3,455 -8.4% 37,520 10 Mar 2024 Common Stock 3,455 Direct F1, F2
transaction GILD Restricted Stock Unit Options Exercise -6,946 -19% 30,574 10 Mar 2024 Common Stock 6,946 Direct F1, F3
transaction GILD Non-qualified Stock Option (Right to Buy) Award $0 +89,660 $0.000000 89,660 10 Mar 2024 Common Stock 89,660 $75.12 Direct F4
transaction GILD Restricted Stock Unit Award +17,640 +58% 48,214 10 Mar 2024 Common Stock 17,640 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2 The restricted stock units have a four-year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested.
F3 The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested.
F4 The shares subject to the option have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.